Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
African Trypanosomiasis - Overview
African Trypanosomiasis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
African Trypanosomiasis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
African Trypanosomiasis - Companies Involved in Therapeutics Development
Cesa Alliance SA
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc
Incuron LLC
MediSynergics LLC
Novartis AG
Paxmedica Inc
Pfizer Inc
Sanofi
Scynexis Inc
Synstar Japan Co Ltd
African Trypanosomiasis - Drug Profiles
acoziborole - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AP-3 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CBL-0137 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DDD-100097 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
fexinidazole - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GNF-6702 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MDL-73811 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
melarsoprol hydroxypropylbetadex - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MS-08 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PAX-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Peptides for Sleeping Sickness - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SCYX-1330682 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SCYX-1608210 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule for African Trypanosomiasis and Chagas Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Infectious Diseases - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Protozoal Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Sleeping Sickness - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit Lanosterol 14 alpha-Demethylase for African Trypanosomiasis, Chagas Disease and Leishmaniasis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit N-Myristoyltransferase for African Trypanosomiasis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit Rhodesain for African Trypanosomiasis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit Variant Surface Glycoprotein for African Trypanosomiasis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
African Trypanosomiasis - Dormant Projects
African Trypanosomiasis - Discontinued Products
African Trypanosomiasis - Product Development Milestones
Featured News & Press Releases
Feb 02, 2021: PaxMedica receives FDA orphan drug desigtion for use of PAX-101 (IV suramin) in a rare tropical disease
Nov 16, 2018: Sanofi: European Medicines Agency recommends fexinidazole, the first all-oral treatment for sleeping sickness
Nov 16, 2018: CHMP recommends first oral-only treatment for sleeping sickness
Jan 31, 2018: Sanofi, DNDi seek European Medicines Agency review for sleeping sickness treatment
Nov 04, 2017: Phase II/III Studies Show High Efficacy and Safety of Fexinidazole, the First Oral Treatment for Sleeping Sickness
Aug 30, 2016: UGA researchers discover a drug for a tropical disease
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for African Trypanosomiasis, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for African Trypanosomiasis, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
African Trypanosomiasis - Pipeline by Cesa Alliance SA, 2021
African Trypanosomiasis - Pipeline by F. Hoffmann-La Roche Ltd, 2021
African Trypanosomiasis - Pipeline by GlaxoSmithKline Plc, 2021
African Trypanosomiasis - Pipeline by Incuron LLC, 2021
African Trypanosomiasis - Pipeline by MediSynergics LLC, 2021
African Trypanosomiasis - Pipeline by Novartis AG, 2021
African Trypanosomiasis - Pipeline by Paxmedica Inc, 2021
African Trypanosomiasis - Pipeline by Pfizer Inc, 2021
African Trypanosomiasis - Pipeline by Sanofi, 2021
African Trypanosomiasis - Pipeline by Scynexis Inc, 2021
African Trypanosomiasis - Pipeline by Synstar Japan Co Ltd, 2021
African Trypanosomiasis - Dormant Projects, 2021
African Trypanosomiasis - Discontinued Products, 2021